Open Letter to the European Commission

The European Society of Endocrinology (ESE), the Endocrine Society (ES), the European Society for Paediatric Endocrinology (ESPE) and the European Thyroid Association (ETA), together representing the majority of European and global experts in endocrine disruptors, feel compelled to react to the European Commission’s proposed delay in the publication of their proposal for the REACH revision to Q4 2023.

Read the Open Letter (PDF)

Go back